These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6151431)

  • 1. Dopamine control of prolactin secretion in multiple endocrine neoplasia type I.
    Dornan J; O'Leary JG; Farid NR
    Clin Invest Med; 1984; 7(3):161-4. PubMed ID: 6151431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric secretion and hormonal interactions in multiple endocrine neoplasia type I.
    Gogel HK; Buckman MT; Cadieux D; McCarthy DM
    Arch Intern Med; 1985 May; 145(5):855-9. PubMed ID: 2859842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.
    Cristina C; Díaz-Torga GS; Goya RG; Kakar SS; Perez-Millán MI; Passos VQ; Giannella-Neto D; Bronstein MD; Becu-Villalobos D
    Mol Cancer; 2007 Jan; 6():4. PubMed ID: 17222350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant multiple endocrine neoplasia I (MEN IBurin): further studies and non-linkage to HLA.
    Bear JC; Briones-Urbina R; Fahey JF; Farid NR
    Hum Hered; 1985; 35(1):15-20. PubMed ID: 2857681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin secretion in the empty sella syndrome, in prolactinomas and in acromegaly.
    Brismar K
    Acta Med Scand; 1981; 209(5):397-405. PubMed ID: 6787839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-existing prolactinoma with primary empty sella.
    Majeed PA; Saini JS; Dash RJ
    J Assoc Physicians India; 1985 Mar; 33(3):241-3. PubMed ID: 4044485
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperprolactinemia in multiple endocrine adenomatosis, type 1.
    Carlson HE; Levine GA; Goldberg NJ; Hershman JM
    Arch Intern Med; 1978 Dec; 138(12):1807-8. PubMed ID: 31144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Type I multiple endocrine neoplasia with prolactin-secreting tumor revealed by pituitary apoplexy (author's transl)].
    Richard JL; Ribstein J; Bringer J; Pages M; Jaffiol C; Mirouze J
    Nouv Presse Med; 1981 Oct; 10(38):3149-52. PubMed ID: 6117057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal structural dopamine type 2 receptor gene in prolactin-secreting and other pituitary tumors.
    Friedman E; Adams EF; Höög A; Gejman PV; Carson E; Larsson C; De Marco L; Werner S; Fahlbusch R; Nordenskjöld M
    J Clin Endocrinol Metab; 1994 Mar; 78(3):568-74. PubMed ID: 7907340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A family with multiple endocrine neoplasia type I presenting prolactinoma, Zollinger-Ellison syndrome and hyperparathyroidism].
    Maru Y; Tachikawa K; Hiraiwa N; Ogino Y; Shishiba Y; Watanabe G; Nakazawa H; Tsurumaru M; Akiyama H; Matsushita H
    Nihon Naibunpi Gakkai Zasshi; 1985 Sep; 61(9):872-81. PubMed ID: 2867939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial multiple endocrine adenomatosis. Multiple endocrine neoplasia, type I.
    Craven DE; Goodman D; Carter JH
    Arch Intern Med; 1972 Apr; 129(4):567-9. PubMed ID: 4401675
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for increased endogenous dopaminergic inhibition of aldosterone secretion in prolactinoma.
    Jungmann E; Schwedes U; Althoff PH; Rosak C; Schöffling K
    Horm Metab Res; 1986 Oct; 18(10):704-5. PubMed ID: 3781476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis, therapy and screening of multiple endocrine neoplasia type I (MEN I) in four endocrinologic centers].
    Schaaf L; Nies G; Raue F; Tuschy U; Seif FJ; Trojan J; Usadel KU
    Med Klin (Munich); 1994 Jan; 89(1):1-6. PubMed ID: 7908402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronobiological study of pituitary adenomas and of the empty sella syndrome.
    Ferrari E; Bossolo PA; Baldi F; Daguati M; Fioravanti M; Facara S
    Chronobiologia; 1982; 9(2):241-8. PubMed ID: 7117046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple endocrine neoplasia type 1. Clinical features and screening.
    Skogseid B; Rastad J; Oberg K
    Endocrinol Metab Clin North Am; 1994 Mar; 23(1):1-18. PubMed ID: 7913018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Case of type I polyglandular syndrome associated with prolactinoma].
    Krassowski J; Grzelec T
    Pol Tyg Lek; 1983 May; 38(18):565-7. PubMed ID: 6138760
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinicopathologic conference. Prolactinoma and hyperaldosteronism in a 55-year-old male: variant of multiple endocrine adenomatosis (MEA) type I?].
    Gieshoff B; Benker G; Windeck R; Reinwein D
    Med Klin (Munich); 1987 May; 82(11):394-9. PubMed ID: 2885732
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of individual tumor syndromes. Pituitary neoplasia.
    McCutcheon IE
    Endocrinol Metab Clin North Am; 1994 Mar; 23(1):37-51. PubMed ID: 7913028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperprolactinemia and the multiple endocrine adenomatosis type 1 (MEA-1) syndrome.
    Levine JH; Sagel J; Rosebrock GL; Gonzalez J
    Arch Intern Med; 1978 Dec; 138(12):1777-8. PubMed ID: 31143
    [No Abstract]   [Full Text] [Related]  

  • 20. "Empty sella" with invasive microprolactinoma.
    Hufnagel TJ; Kim JH; Wiedenmann JD; Silbert JA
    Clin Neuropathol; 1989; 8(3):126-9. PubMed ID: 2743648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.